Anthropic launches AI drug discovery program, joining tech giants in betting on healthcare

Anthropic, an AI company, is starting its own drug discovery program to develop AI tools for pharmaceutical companies, focusing on treatments for neglected diseases (illnesses that traditional drug makers ignore because they're not profitable). The company believes that by doing its own drug research alongside pharmaceutical partners, it can build better AI products and get direct feedback on what drugmakers actually need.